-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Azacitidine + Cedazuridine) in Refractory Anemia With Excess Blasts
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Azacitidine + Cedazuridine) in Refractory Anemia With Excess Blasts report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Azacitidine + Cedazuridine) in Refractory Anemia...
-
Product Insights
NewLikelihood of Approval Analysis for Hypersomnia
Overview How likely is it that the drugs in Hypersomnia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypersomnia Overview Hypersomnia is a neurological disorder of excessive time spent sleeping or...
-
Product Insights
NewLikelihood of Approval Analysis for Narcolepsy
Overview How likely is it that the drugs in Narcolepsy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Narcolepsy Overview Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent...
-
Product Insights
NewLikelihood of Approval Analysis for Axillary Hyperhidrosis
Overview How likely is it that the drugs in Axillary Hyperhidrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axillary Hyperhidrosis Overview Axillary hyperhidrosis also referred to as excessive underarm sweating....
-
Product Insights
NewLikelihood of Approval Analysis for Congestive Heart Failure (Heart Failure)
Overview How likely is it that the drugs in Congestive Heart Failure (Heart Failure) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Congestive Heart Failure (Heart Failure) Overview Heart failure (HF),...
-
Product Insights
NewLikelihood of Approval Analysis for Epilepsy
Overview How likely is it that the drugs in Epilepsy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Epilepsy Overview Epilepsy is a group of non-communicable neurological disorders characterized by recurrent...
-
Product Insights
NewLikelihood of Approval Analysis for IgA Nephropathy (Berger’s Disease)
Overview How likely is it that the drugs in IgA Nephropathy (Berger's Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IgA Nephropathy (Berger's Disease) Overview IgA nephropathy, also known as...
-
Product Insights
NewLikelihood of Approval Analysis for Polycythemia Vera
Overview How likely is it that the drugs in Polycythemia Vera will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polycythemia Vera Overview Polycythemia vera (PV) is a stem cell disorder characterized...
-
Product Insights
NewLikelihood of Approval Analysis for Vulvovaginal Candidiasis
Overview How likely is it that the drugs in Vulvovaginal Candidiasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vulvovaginal Candidiasis Overview An excessive growth of yeast in the vagina that...
-
Product Insights
NewLikelihood of Approval Analysis for Hemophilia B (Factor IX Deficiency)
Overview How likely is it that the drugs in Hemophilia B (Factor IX Deficiency) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hemophilia B (Factor IX Deficiency) Overview Hemophilia B is...